Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-04-04

Clinical Trial Update: Trial to Evaluate Safety and Immunogenicity of an Ebola Zaire Vaccine in Healthy Adults [Phase 1]

View source ↗

Summary

Phase 1 clinical trial update assessing safety and immunogenicity of an Ebola Zaire vaccine in healthy adults.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Ebola Zaire vaccine

Snippet

Sponsor: Auro Vaccines LLC | Conditions: Ebola Virus Disease | Phase 1 | Status: COMPLETED